M R Wilkins1, A Aldashev, N W Morrell. Show Affiliations » 1. Section on Clinical Pharmacology, Imperial College School of Medicine, Hammersmith Hospital, London W12 ONN, UK. m.wilkins@ic.ac.uk
Abstract
Entities: Chemical Disease
Mesh： See more » 3',5'-Cyclic-GMP Phosphodiesterases/antagonists & inhibitorsAdaptation, PhysiologicalAltitude Sickness/etiologyAltitude Sickness/metabolismAltitude Sickness/prevention & controlAnimalsBoliviaHumansHypertension, Pulmonary/ethnologyHypertension, Pulmonary/etiologyHypertension, Pulmonary/metabolismHypertension, Pulmonary/prevention & controlHypoxia/complicationsHypoxia/metabolismNitric Oxide/metabolismOxygen/metabolismPhosphodiesterase Inhibitors/pharmacologyRatsTibet
Substances： See more » Phosphodiesterase InhibitorsNitric Oxide3',5'-Cyclic-GMP PhosphodiesterasesOxygen
Year: 2002 PMID： 12047961 DOI： 10.1016/s0140-6736(02)08528-8
Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321